Goldman Sachs Group Inc. disclosed the purchase of 500,000 shares of Attovia Therapeutics, Inc. (ATTO) on the open market on August 6, 2026, according to a Form 4 filed with the SEC. The shares were bought at $17.00 apiece for a total outlay of $8,500,000. Following the transaction, Goldman Sachs holds 3,020,632 shares indirectly, through … Read more
Huang Jack Jiajia, the Chief Executive Officer, a director, and a 10%+ owner of 51Talk Online Education Group (COE), disclosed another open-market purchase of company stock in a Form 4 filing. On August 10, 2026, Huang bought 199,980 shares at $19.72 apiece, a purchase worth $3,943,605.60. Following the transaction, Huang’s indirect holdings — reported as … Read more
A fresh Form 4 filing shows Cascade Investment, L.L.C., a 10%+ owner of Republic Services, Inc. (NYSE: RSG), purchased 3,200 shares of the waste-management giant on August 11, 2026, at $214.67 per share. The single transaction was worth $686,951.36 and lifted Cascade’s directly held stake to 111,068,846 shares. That trade, however, is just one piece … Read more
A fresh Form 4 filing shows Carl L. Gordon, a director of BlossomHill Therapeutics, Inc. (BLSM), purchased 625,000 shares of the company on the open market on August 10, 2026. The transaction, priced at $16.00 per share, totaled $10,000,000.00 — a purchase made with the insider’s own funds rather than acquired through options or other … Read more
A director of BlossomHill Therapeutics, Inc. (BLSM) put real money on the table this week. According to a Form 4 filing, OrbiMed Advisors LLC purchased 625,000 shares of BlossomHill on August 10, 2026, in an open-market transaction priced at $16.00 per share. The total outlay came to an even $10,000,000.00, funded directly by the insider … Read more
Liberty Capital Corp/NV (GLIBK) disclosed another insider purchase this week, with director and 10%+ owner John C. Malone buying 66,702 shares on August 12, 2026 at $25.57 per share, a purchase worth $1,705,623.50. Following the transaction, Malone’s directly held stake stands at 2,558,752 shares. The filing is notable less for its standalone size than for … Read more
OrbiMed Advisors LLC, a director and 10%-plus owner of Braveheart Bio, Inc. (BRVE), disclosed an open-market purchase of 1,666,667 shares at $18.00 apiece, a cash outlay of $30,000,006.00, according to a Form 4 filed with the SEC. The transaction is dated August 7, 2026, and brings OrbiMed’s indirectly held stake to 11,901,826 shares. The purchase … Read more
TXO Partners, L.P. (TXO) insider Bob R. Simpson disclosed an open-market purchase of 100,000 shares on August 11, 2026, paying $14.27 per share for a total outlay of $1,427,480. Following the trade, Simpson’s directly held stake stands at 9,350,000 shares, according to the Form 4 filed with the SEC. The purchase was made with Simpson’s … Read more
A newly filed Form 4 with the Securities and Exchange Commission shows that Bankers Life & Casualty Co., acting in its capacity as a 10%+ owner, purchased a substantial block of shares in Privacore VPC Asset Backed Credit Fund on August 7, 2026. The filing shows no ticker symbol associated with the fund, consistent with … Read more
Aptiv PLC (APTV) Chair and CEO Kevin P. Clark disclosed an open-market purchase of 51,190 shares on August 10, 2026, according to a Form 4 filing with the SEC. The shares were bought at $48.89 apiece, for a total outlay of $2,502,684.22. Following the transaction, Clark holds 651,016 shares directly, a stake that reflects a … Read more
Fortune Brands Innovations, Inc. (NYSE: FBIN) disclosed a fresh round of insider buying this week, with Chief Executive Officer Jesse G. Singh adding a substantial block of shares to his personal holdings, according to a Form 4 filed with the SEC. On August 7, 2026, Singh purchased 19,560 shares of FBIN on the open market … Read more
Foresite Capital Management V, LLC, a 10%+ owner of Latigo Biotherapeutics, Inc. (LTGO), disclosed an open-market purchase of 140,000 shares on August 10, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The shares were bought at $18.00 apiece, for a total transaction value of $2,520,000.00. This was a straightforward open-market … Read more